Also trades as: TTKHEALTH.BO (BSE) · $vol 0M

₹1,009.00 ($10.48)

-4.00 (-0.39%)

NSE · Healthcare · Drug Manufacturers - General · Tech Score Sell · Power 40 · ₹14.3B mcap · 3M float · 0.844% daily turnover

Analysis Technicals Weather Peers

Revenue

$8.6B -1.8% ▼

5Y CAGR: +12.5%

Gross Profit

$2.8B -44.5% ▼

5Y CAGR: +15.2%

Operating Income

$174M -95.1% ▼

5Y CAGR: +19.9%

Net Income

$657M -19.6% ▼

5Y CAGR: +7.2%

EPS (Diluted)

$46.48 -19.6% ▼

5Y CAGR: +7.2%

EBITDA

$262M -75.3% ▼

5Y CAGR: -6.9%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$6.0B	$7.3B	$7.5B	$8.7B	$8.6B
YoY Growth	+25.9%	+21.0%	+3.1%	+16.7%	-1.8%
Cost of Revenue	$2.9B	$3.5B	$3.4B	$3.7B	$5.8B
Gross Profit	$3.1B	$3.8B	$4.1B	$5.0B	$2.8B
Gross Margin	51.6%	52.0%	54.5%	57.7%	32.6%
R&D Expenses	$29M	$13M	$11M	$2M	$0
SG&A Expenses	$1.3B	$1.4B	$1.5B	$2.6B	$0
Operating Expenses	$3.0B	$3.6B	$2.0B	$1.5B	$2.6B
Operating Income	$93M	$187M	$1.5B	$3.5B	$174M
Operating Margin	1.5%	2.6%	19.6%	40.4%	2.0%
Interest Expense	$32M	$52M	$28M	$33M	$29M
Income Before Tax	$248M	$616M	$841M	$1.1B	$826M
Tax Expense	$63M	$170M	$213M	$267M	$169M
Net Income	$416M	$6.4B	$628M	$817M	$657M
Net Margin	6.9%	88.2%	8.4%	9.4%	7.7%
EPS (Diluted)	$29.43	$452.73	$44.47	$57.79	$46.48
EBITDA	$407M	$797M	$999M	$1.1B	$262M
Shares Outstanding	14M	14M	14M	14M	14M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$2.1B	$2.0B	$2.0B	$1.9B	$2.3B	$2.0B	$2.1B	$2.2B
Cost of Revenue	$1.3B	$1.3B	$980M	$74M	$1.0B	$1.4B	$1.4B	$1.1B
Gross Profit	$740M	$689M	$1.1B	$2.5B	$1.2B	$624M	$677M	$1.1B
Gross Margin	35.6%	34.7%	52.1%	133.6%	55.0%	30.7%	32.4%	51.3%
R&D Expenses	$0	$0	$0	$2M	$0	$0	$0	$0
SG&A Expenses	$691M	$627M	$0	$364M	$806M	$593M	$628M	$598M
Operating Expenses	$691M	$627M	$1.0B	-$820M	$1.2B	$593M	$628M	$1.0B
Operating Income	$49M	$62M	$56M	$3.4B	$5M	$31M	$49M	$89M
Operating Margin	2.3%	3.1%	2.7%	176.6%	0.2%	1.5%	2.3%	4.1%
Interest Expense	$9M	$7M	$8M	$9M	$8M	$8M	$7M	$6M
Income Before Tax	$408M	$232M	$226M	$218M	$177M	$213M	$141M	$295M
Tax Expense	$92M	$60M	$59M	$56M	$47M	$9M	$36M	$78M
Net Income	$316M	$172M	$167M	$161M	$130M	$204M	$105M	$218M
Net Margin	15.2%	8.7%	8.2%	8.5%	5.7%	10.0%	5.0%	10.0%
EPS (Diluted)	$22.35	$12.17	$11.84	$11.43	$9.20	$14.43	$7.45	$15.40
EBITDA	$437M	$259M	$255M	$306M	$206M	$243M	$170M	$323M
Shares Outstanding	14M	14M	14M	14M	14M	14M	14M	14M

TTKHLTCARE.NS NSE